[68Ga]FAPI-46
19097
Approved small_molecule active
Quick answer
[68Ga]FAPI-46 for post-acute sequelae of COVID-19 is a Approved program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- post-acute sequelae of COVID-19
- Phase
- Approved
- Modality
- small_molecule
- Status
- active